Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology

Slides:

Advertisements

Similar presentations

BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.

Advertisements

Flow Diagram of the Main HOPE Trial and the HOPE-TOO Trial Extension The HOPE and HOPE-TOO Trial Investigators JAMA. 2005;293:

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Safety and Efficacy of Low Blood Pressures Among.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Tolerability and efficacy of carvedilol in patients.

Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:

Summary of “A randomized trial of standard versus intensive blood-pressure control” The SPRINT Research Group, NEJM, DOI: /NEJMoa Downloaded.

Date of download: 11/13/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Reality of Heart Failure in Latin America J.

Volume 64, Issue 6, Pages (December 2014)

Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study Dr Jack R W Brownrigg,

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease Ramon Berguer, MD, PhD, Mark D. Morasch,

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

The obesity paradox in men with coronary heart disease and heart failure: The role of muscle mass and leptin S. Goya Wannamethee, A. Gerald Shaper, Peter.

Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials Sripal Bangalore, MD, MHA, Bora Toklu,

Fig. 1 (A) Systolic (open symbols) and diastolic (closed symbols) blood pressure in vehicle (0.1% DMSO) (○, ●) and 2.3×10−5 g/kg (△, ▴) resveratrol-infused.

Volume 55, Issue 3, Pages (May 2010)

Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: Implications for timing.

Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /

Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.

Usefulness of Matrix Metalloproteinase-9 Plasma Levels to Identify Patients With Preserved Left Ventricular Systolic Function After Acute Myocardial Infarction.

Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.

Comparison of chronic type A aortic dissection with acute type A dissection of short-term and long-term survival rate Qinghua Yuan, Hui Yu, Ujit Karmacharya,

Management of hypertension in patients with chronic kidney disease

Milen Pavlović, Nebojša Jović, Tatjana Pekmezović

Journal of Indian College of Cardiology

PDE5 inhibitor sildenafil in the treatment of heart failure: A meta-analysis of randomized controlled trials Xiao-Dong Zhuang, Ming Long, Fei Li, Xun.

Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials Sripal Bangalore, MD, MHA, Bora Toklu,

Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without.

Surgical treatment of atypical aortic coarctation complicating Takayasu’s arteritis— experience with 33 cases over 44 years Tsuyoshi Taketani, MD, Tetsuro.

Surgical therapy for ischemic heart failure: Single-center experience with surgical anterior ventricular restoration Lorenzo Menicanti, MD, Serenella.

Hypertension management in high risk type II diabetes with CKD: Insights from recent trials with a focus on albuminuria. A case based discussion Matthew.

Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric K. Peden, MD, Imran T

Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology

Non-cardiovascular comorbidity, severity and prognosis in non-selected heart failure populations: A systematic review and meta-analysis C.A. Rushton,

Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy Scott J. Denardo, MD, Yan Gong, PhD, Wilmer.

Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.

Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience Tetsuma Kawaji, Satoshi.

Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death

Amy C. Arnold, PhD, MSCI, Satish R. Raj, MD, MSCI

J. Hofland, I. GuÕltuna, R. Tenbrinck British Journal of Anaesthesia

Competing risks need to be considered in survival analysis models for cardiovascular outcomes Marianne Huebner, PhD, Martin Wolkewitz, Dr Sc Hum, Maurice.

Svend A. Mortensen et al. JCHF 2014;2:

Risks for Cardiovascular and Cardiac Deaths in Nonobese Patients With Diabetes and Coronary Heart Disease Tetsuro Tsujimoto, MD, PhD, Hiroshi Kajio,

International Journal of Cardiology

Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease Tetsuro Tsujimoto, Hiroshi Kajio

Long-term follow-up of mitral valve regurgitation��Importance of mitral valve pathology and left ventricular function on survival Krister Lindmark,

Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression Corline Brouwers, Stefan.

Comparison of the GRACE, HEART and TIMI score to predict major adverse cardiac events in chest pain patients at the emergency department J.M. Poldervaart,

Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction

Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) study Hiroshi.

Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study Victor Shi, Michele Senni, Hendrik.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Heated water-based exercise training reduces 24-hour ambulatory blood pressure levels in resistant hypertensive patients: A randomized controlled trial.

Receiver operating characteristic curves for the association of primary outcome using each clinical risk score and each clinical risk score adjusted for.

Cumulative survival without events during 1 year in patients with preserved systolic function (left ventricular ejection fraction (LVEF) >40%) and with.

Flow chart of the 1683 study members at age 60–64 years by hypertension (HT) status. Flow chart of the 1683 study members at age 60–64 years by hypertension.

The ACCORD Study Group. NEJM 2010; Epub March 14

Left ventricular remodeling in patients with acute type B aortic dissection after thoracic endovascular aortic repair: Short- and mid-term outcomes Yukui.

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley

Connie W. Tsao et al. JCHF 2016;4:

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

EFFECTS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS ON MORTALITY, CARDIOVASCULAR HOSPITALIZATION AND FUNCTIONAL CAPACITY IN PATIENTS WITH HEART.

Steven R. Steinhubl, and Eric J. Topol JACC 2015;66:

Kaplan-Meier survival estimates for major cardiovascular events.

Should patient age be a consideration in carotid endarterectomy?

J. David Spence, BA, MBA, MD Canadian Journal of Cardiology

Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.

Time to first event analysis revealed a significant difference in estimated event-free (death or hospitalisation) survival between patients with left ventricular.

International Journal of Cardiology

Relationship between 6-month all-cause mortality and the three types of heart failure adjusted for age ≥75 years, peripheral edema at admission, systolic.

Presentation transcript:

Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology DOI: 10.1016/j.ijcard.2018.04.031 Copyright © 2017 Terms and Conditions

Fig. 1 Kaplan–Meier survival curves for primary and secondary outcomes based on diastolic blood pressure groups. Rates of freedom from primary outcome events (A), all-cause death (B), cardiovascular events (C), and hospitalization for heart failure (D). International Journal of Cardiology DOI: (10.1016/j.ijcard.2018.04.031) Copyright © 2017 Terms and Conditions

Fig. 2 Kaplan–Meier survival curves and cumulative event rates for primary and secondary outcomes based on diastolic blood pressure groups in patients with a systolic blood pressure of ≥120 mm Hg. Rates of freedom from primary outcome events (A), all-cause death (B), major cardiovascular events (C), and hospitalization for heart failure (D). International Journal of Cardiology DOI: (10.1016/j.ijcard.2018.04.031) Copyright © 2017 Terms and Conditions